Conforms to 93/112/EC and ISO 11014-1
Material Safety Data Sheet
EM2-IL6 Standard Diluent
6928
1856925 1900931
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
9/15/2005
9/15/2005
Product name
Supplier
Manufacturer
Product No.
MSDS#
Validation Date
Print Date
In Case of Emergency
Section 1. Chemical Product and Company Identification
Responsible Name MSDS Administrator
Intended Use Refer to the instruction booklet for proper and intended use. Otherwise, contact supplier for specific applications.
Eng
In USA:
In Europe:
Pierce
Perbio Science
P.O. Box 117
Industriezone III
Rockford, IL 61105 Industrielaan 27
USA
9320 Erembodegem-Aalst
815.968.0747 or
Belgium
1.800.874.3723
Tel:+32 53 83 44 04
Fax:+32 53 83 76 38
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
USA
815.968.0747 or
1.800.874.3723
Substance/Preparation
Preparation
:
Section 2. Composition, Information on Ingredients
CAS number
Ingredient name
%
EC number
Classification
Sodium Azide
26628-22-8
0 - 0.1
247-852-1
T+; R28
R32
N; R50/53
Eye contact. Inhalation. Ingestion.
Emergency Overview
Medical Conditions Aggravated
by Overexposure:
Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one or
many human organs.
Not available.
Overexposure /Signs/Symptoms
Section 3. Hazards Identification
Routes of Entry
Carcinogenic Effects Data CARCINOGENIC EFFECTS: Classified None. by NIOSH [Sodium Azide]. Classified A4 (Not classifiable for human or
animal.) by ACGIH [Sodium Azide].
MUTAGENIC EFFECTS: Classified SUSPECTED for human [Sodium Azide].
TERATOGENIC EFFECTS: Not available.
Review the most current and approved institutional guideline, protocol, standard operating procedure(s) and MSDS(s)
for the proper handling of institutional materials/equipment associated with the use of this product.
No specific hazard.
United States
Europe
Potential acute health effects
No known significant effects or critical hazards.
No known significant effects or critical hazards.
No known significant eff